Markers of dispute

被引：10

作者：

Hughes, Virginia

机构：

[1] Virginia Hughes is a freelance journalist based in Brooklyn,

[2] New York.,undefined

来源：

NATURE MEDICINE | 2009年 / 15卷 / 12期

关键词：

PROSTATE-SPECIFIC ANTIGEN; SERUM MARKER; CANCER; CARCINOMA; MORTALITY; EPCA-2;

D O I：

10.1038/nm1209-1339

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The gold standard for early detection of prostate cancer, PSA, has recently come under fire for its high rate of false positives. Virginia Hughes investigates some of the researchers hunting for better alternatives and asks whether their promises of creating viable-and profitable-biomarker tests will ever be realized.

引用

页码：1339 / 1343

页数：5

共 12 条

[1] Mortality Results from a Randomized Prostate-Cancer Screening Trial [J].

Andriole, Gerald L. ;

Grubb, Robert L., III ;

Buys, Saundra S. ;

Chia, David ;

Church, Timothy R. ;

Fouad, Mona N. ;

Gelmann, Edward P. ;

Kvale, Paul A. ;

Reding, Douglas J. ;

Weissfeld, Joel L. ;

Yokochi, Lance A. ;

Crawford, E. David ;

O'Brien, Barbara ;

Clapp, Jonathan D. ;

Rathmell, Joshua M. ;

Riley, Thomas L. ;

Hayes, Richard B. ;

Kramer, Barnett S. ;

Izmirlian, Grant ;

Miller, Anthony B. ;

Pinsky, Paul F. ;

Prorok, Philip C. ;

Gohagan, John K. ;

Berg, Christine D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (13) :1310-1319

[2]

[Anonymous], WASHINGTON POST

[3] POINT: EPCA-2: A promising new serum biomarker for prostatic carcinoma? [J].

Diamandis, Eleftherios P. .

CLINICAL BIOCHEMISTRY, 2007, 40 (18) :1437-1439

[4] Rethinking Screening for Breast Cancer and Prostate Cancer [J].

Esserman, Laura ;

Shieh, Yiwey ;

Thompson, Ian .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (15) :1685-1692

[5]

GETZENBERG RH, 1991, CANCER RES, V51, P6514

[6] PROSTATE-CANCER SCREENING - WHAT WE KNOW AND WHAT WE NEED TO KNOW [J].

KRAMER, BS ;

BROWN, ML ;

PROROK, PC ;

POTOSKY, AL ;

GOHAGAN, JK .

ANNALS OF INTERNAL MEDICINE, 1993, 119 (09) :914-923

[7] RETRACTED: EPCA-2: A highly specific serum marker for prostate cancer (Retracted Article) [J].

Leman, Eddy S. ;

Cannon, Grant W. ;

Trock, Bruce J. ;

Sokoll, Lori J. ;

Chan, Daniel W. ;

Mangold, Leslie ;

Partin, Alan W. ;

Getzenberg, Robert H. .

UROLOGY, 2007, 69 (04) :714-720

[8] Screening and Prostate-Cancer Mortality in a Randomized European Study [J].

Schroeder, Fritz H. ;

Hugosson, Jonas ;

Roobol, Monique J. ;

Tammela, Teuvo L. J. ;

Ciatto, Stefano ;

Nelen, Vera ;

Kwiatkowski, Maciej ;

Lujan, Marcos ;

Lilja, Hans ;

Zappa, Marco ;

Denis, Louis J. ;

Recker, Franz ;

Berenguer, Antonio ;

Maattanen, Liisa ;

Bangma, Chris H. ;

Aus, Gunnar ;

Villers, Arnauld ;

Rebillard, Xavier ;

van der Kwast, Theodorus ;

Blijenberg, Bert G. ;

Moss, Sue M. ;

de Koning, Harry J. ;

Auvinen, Anssi .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (13) :1320-1328

[9] Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers [J].

Shariat, Shahrokh F. ;

Karam, Jose A. ;

Walz, Jochen ;

Roehrborn, Claus G. ;

Montorsi, Francesco ;

Margulis, Vitaly ;

Saad, Fred ;

Slawin, Kevin M. ;

Karakiewicz, Pierre I. .

CLINICAL CANCER RESEARCH, 2008, 14 (12) :3785-3791

[10]

Smith DS, 1997, CANCER, V80, P1852

← 1 2 →